Phase 3, double-blind, placebo-controlled, multi-center study to assess the safety and efficacy of Exenatide once weekly in adolescents with type 2 diabetes
This study seeks to evaluate the effect of an experimental drug in children and adolescents with type 2 diabetes mellitus.
Those eligible to participate in this study include:
Interactive Campus Map
2500 North State Street
Jackson, MS 39216
General Information: 601-984-1000
Patient Appointments: 888-815-2005